• Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

  • Feb 6 2025
  • Length: 33 mins
  • Podcast

Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

Listen for free

View show details

  • Summary

  • Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity.

    https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha

    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp
    📱 Amazon Kindle Reader: https://amzn.to/4gAXrz4
    📖Paperback: https://amzn.to/4gAXrz4

    💊 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
    USE CODE "OTP10" to save 10%.

    SOCIALS:
    📸 : https://www.instagram.com/onthepen.official/profilecard/?igsh=dTRhY3JkYWo1bTIx
    🇨🇳: https://www.tiktok.com/@manonthemounjaro?_t=ZP-8sr5PrUuPQl&_r=1
    👾: https://discord.gg/ZHeUh7WV
    📺: https://youtube.com/@ManOnTheMounjaro?feature=shared
    ❌: https://x.com/manonthepen?s=21
    💻: https://www.onthepen.com
    Show More Show Less
Show More Show Less

What listeners say about Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.